Clinical Trial Update: A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating HS135 for pulmonary arterial hypertension in adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• HS135

Snippet

Sponsor: 35Pharma Inc | Conditions: Pulmonary Arterial Hypertension (PAH) | Phase 1 | Status: TERMINATED